News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Walk News

Click on a headline to read the latest about Parkinson's Unity Walk. 


Every Step Counts at the 21st Parkinsonís Unity Walk on April 25th at Central Park in New York City

Congratulations to the Winner of the Hotel Gift Card

Register Early For a Chance to Win a Hotel Gift Card

Download the Unity Walk Mobile App and Fundraise on the Go.

Your Dollars at Work Ė 2014 Parkinson's Unity Walk Research Grants Have Been Awarded

20th Parkinson's Unity Walk Raises More Than $1.6 Million in Donations for Parkinson's Research

Top 50 Teams - Parkinson's Unity Walk 2014

Poem by Maryum "May May" Ali Read at the 20th Parkinson's Unity Walk

Join us on the Plaza of the Today Show, Friday Morning, April 25, 2014

20th Parkinson's Unity Walk to Take Place on April 26 in New York City's Central Park

Send us Your Favorite Walk Momentóand Your Photo Could be Part of the Walkís Slideshow

PUW is Up in Lights!

Parkinsonís Unity Walk Partners with Teva to Raise Awareness of Parkinsonís Disease

back to top

Sponsor & Foundation News

Participants Invited to Take Survey on Patience and Well-Being in Parkinsonís Disease

Adamas Pharmaceuticals' Phase 2/3 Clinical Study Published in Movement Disorders

UCB and Neuropore Enter Into World-Wide Collaboration and Agreement

U.S. FDA Approves AbbVieís DUOPAô Enteral Suspension for Treatment of Advanced PD

Autonomic Dysfunction in Parkinsonís Disease With and Without Deep Brain Stimulation

CE Mark for Boston Scientificís Verciseô DBS System for Treating Tremors

Teva Recalls Generic Parkinsonís Drug

Medtronic Buys Sapiens SBS

The Michael J. Fox Foundation for Parkinsonís Research Awards $2M Grant to Biotie for Parkinson's Dementia Clinical Study

The Michael J. Fox Foundation for Parkinson's Research Awards Second Grant to Cynapsus Therapeutics

Speech Treatment for Parkinson Disease: The Science and Practice of LSVT LOUDô

Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson`s Disease and Movement Disorders

Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Verciseô DBS System For Patients With Parkinson's Disease

National Parkinson Foundation Study Finds U.S. Neurologist Care Saves 4,600 Lives of People with Parkinsonís Disease Each Year

AbbVie Announces Availability of New Advanced Parkinson`s Treatment in Canada

Boston Scientific Corporation Enrolls the First Patient in a New Registry to Evaluate the Value of the Verciseô Deep Brain Stimulation (DBS) System

MRI Interventions' Clearpoint System Now Utilized at Emory University in Atlanta

back to top

News in the Parkinson's Disease Community

Skin Test May Aid in Diagnosis of Parkinsonís and Alzheimerís

Pharma Two B Completes Enrollment in Phase IIb Study of P2B001 for PD

Implanted Stem Cells Reduced Symptoms of PD during Experiment

Data from Trial in Advanced PD Patients Using Levodopa-Carbidopa Intestinal Gel

First Discovery of a Physical Predictor of Freezing in PD

Eltoprazine Could Tackle Dyskinesia Side Effect in Parkinsonís Disease

Biotie Provides Update on Tozadenant

Recent Clinical Study Offers Hope for Potential Parkinson's Disease Therapies

Creatine Has No Effect on Progression of Parkinson's Disease

Breath Test for Parkinson's Disease

Parkinsonís Study Dims Ambitions for Gene Flaw Carried by Brin

Blue Light Potential for Parkinson's Treatment

Tipping point of Parkinson's Disease discovered by Cambridge University Researchers

Drinking Beer Slows Down Parkinson's and Alzheimer's Disease

Researchers Identify Two mRNA Biomarkers for Parkinson's Disease

Neurologists Find Movement Tracking Device Helps Assess Severity of PD

Blood Test Aims to Detect Parkinson's in Early Stages

LTI Receives Funding for Research Aimed at Delaying or Preventing Parkinsonís Disease

Scientists Find Drug Candidates Can Block Cell Death Pathway Associated with PD

Portable Device Could Be Used to Treat Parkinsonís Disease

23andMe and Genentech to Analyze Genomic Data for Parkinson's Disease

Researchers Discover Molecule that May Lessen Severity of Parkinson's Disease

FDA Approves Rytary, Extended-Release Oral Treatment for PD

PD Patients Improve Strength, Quality Of Life With Exercise

Canadian Researchers Studying New Target for Parkinsonís Treatment

EU Recommends Parkinsonís Drug for Approval

Treating Parkinsonís Disease with Targeted Therapeutic Vaccines

Safinamide New Drug Application Re-submitted to the FDA

back to top